NCT04001257View on ClinicalTrials.gov

18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions
Positron Emission TomographyGlioma
Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT04001257 - 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma | Biotech Hunter | Biotech Hunter